Prodyut Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 94.74%
- Ebitda 95.86%
- Net Worth -1.57%
- Total Assets -2.73%
About Prodyut Biotech
Prodyut Biotech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2007 and has a history of 17 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Innovative Creations Business Modules Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Randhir Gajraj and Chandrakant Gawade serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900MH2007PTC174630
-
Company No.
174630
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Prodyut Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Randhir Gajraj
|
Director | 30-Nov-2017 | Current |
|
Chandrakant Gawade
|
Director | 30-Nov-2017 | Current |
Financial Performance of Prodyut Biotech.
Prodyut Biotech Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.74% increase in profit. The company's net worth dipped by a decrease of 1.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prodyut Biotech?
In 2019, Prodyut Biotech had a promoter holding of 66.66% and a public holding of 33.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sabran Bioenttri Private LimitedRandhir Gajraj is a mutual person
-
Wil Intetrnational LimitedChandrakant Gawade is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prodyut Biotech?
Unlock and access historical data on people associated with Prodyut Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prodyut Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prodyut Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
